Gordon, K., K. Papp, M. Gooderman, D. Thaci, P. Foley, A. Morita, S. Kundu, R. Kisa, A. Napoli, and S. Banerjee. “Influence of Baseline demographics/Disease Characteristics on Efficacy of an Oral Selective TYK2 Inhibitor, BMS-986165, in Patients With Moderate to Severe Plaque Psoriasis: Phase 2, Randomized, Placebo-Controlled Trial”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S14, doi:10.25251/skin.3.supp.14.